期刊文献+

聚集素和Caspase-3在非小细胞肺癌中的表达及意义 被引量:3

The expression and significance of Clusterin and Caspase-3 in non-small cell lung cancer
下载PDF
导出
摘要 目的探讨聚集素(C lusterin)和Caspase-3蛋白在非小细胞肺癌(NSCLC)组织中的表达及与临床病理特征之间的关系及意义。方法采用免疫组织化学方法(SP法)检测C lusterin与Caspase-3蛋白在52例NSCLC组织和20例正常肺组织中的表达情况,结合临床病理资料进行分析。结果 52例肺癌组织中C lusterin阳性表达率为78.85%,20例正常肺组织中的阳性表达率为10%,两者有显著性差异(P<0.05),C lusterin的阳性表达与肿瘤的分化程度、TNM分期及淋巴结转移有关(P<0.05),而与肿瘤的病理类型无关(P>0.05)。52例NSCLC组织中Caspase-3的阳性表达率为44.23%,20例正常肺组织中的阳性表达率为80%,两者差异显著(P<0.05),Caspase-3的阳性表达与肿瘤的分化程度、淋巴结转移有关(P<0.05),而与肿瘤的病理类型、TNM分期无关(P>0.05)。C lusterin与Caspase-3在NSCLC组织中的表达呈负相关。结论 C lusterin过表达及Caspase-3的失表达可能促进了肿瘤的恶性增殖及转移,联合检测C lusterin与Caspase-3对判断NSCLC恶性程度、转移潜能及预后有重要临床意义。 Objective To investigate the correlatetion of the expression and clinicopathologic significance of clusterin and caspase-3 protein in non-small cell lung cancer(NSCLC).Methods The expression of clusterin and caspase-3 protein in 52 cases of lung cancer and 20 cases of normal lung tissue were detected by SP immunohistochemistry method,and the clinicopathologic features of lung cancer were analyzed statistically.Results The positive rate of clusterin protein expression in 52 cases of NSCLC was 78.85%,while in benign tissue was 10%(P〈0.05);the positive rate of clusterin protein expression was closely related to degree of cell differentiation,TNM staging,and lymph node metastasis(P〈0.05),while not to tumor pathological types(P〉0.05).The positive rate of caspase-3 protein expression in 52 cases of NSCLC was 44.23%,while in benign tissue was 80%(P〈0.05);the positive rate of caspase-3 protein expression was closely related to degree of cell differentiation,and lymph node metastasis(P〈0.05),while not to tumor pathological typers and TNM staging(P〉0.05).Negative correlations were observed between the expression of clustein and caspase-3 in NSCLC(P〈0.05).Conclusion Overexpression of clusterin and low expression of caspase-3 may promote the malignant hyperplasy and metastasis of tumor.Co-detected method of the expression levels of the two proteins in NSCLC has important significance in analyzing the degree of malignancy,the potential capacity of metastasis and prognosis.
出处 《临床肿瘤学杂志》 CAS 2010年第8期712-716,共5页 Chinese Clinical Oncology
关键词 非小细胞肺癌 CLUSTERIN CASPASE-3 凋亡 免疫组织化学 Non-small cell lung cancer Clusterin Caspase-3 Apoptosis Immunohistochemistry
  • 相关文献

参考文献4

二级参考文献36

  • 1Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens [J]. Nat Med, 1998,4(7): 844-847.
  • 2Sarosdy MF, White RW, Soloway MS, et al. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer [J]. J Urol, 1995,154(2Pt 1 ): 379-384.
  • 3Trougakos IP, Gonos ES. Functional analysis of clusterin/apolipoprotein J in cellular death induced by severe genotoxic stress [J]. Annv N Y Acad Sci, 2004,1019:206-210.
  • 4Miyake H, Gleave M, Kamidono S, et al. Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence [J]. Urology,2002,59(1): 150-154.
  • 5Nocito A, Kononen J, Kallioniemi OP, et al. Tissue microarrays (TISSUE MICROARRAYs) for high-throughput molecular pathology research [J]. Int J Cancer, 2001,94 (1):1-5.
  • 6Torhorst J, Bucher C, Bubendorf L, et al. Tissue microarrays ('tissue chips') for high-throughput cancer genetics: linking molecular changes to clinical endpoints [J]. Am J Hum Genet, 1999,65(suppl) :43-45.
  • 7Bubendorf L, Kolmer M, Kononen J, et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays [J]. J Natl Cancer Inst, 1999,91(20): 1758-1764.
  • 8Chung J, Kwak C, Jin RJ, et al. Enhanced chemosensitivity of bladder cancer cells to cisplatin by suppression of clusterin in vitro [J]. Cancer Lett, 2004,203(2):155-161.
  • 9Barlund M, Forozan F, Kononen J, et al. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis [J]. J Natl Cancer Inst, 2000,92(15): 1252-1259.
  • 10Moch H, Schraml P, Bubendorf L, et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma [J]. Am J Pathol, 1999,154(4) :981-986.

共引文献32

同被引文献44

  • 1邹宁,宫卫东,周媛,张积仁.ConA识别的高甘露糖型糖蛋白在肿瘤患者血清中表达的研究[J].广东医学,2006,27(6):859-860. 被引量:9
  • 2牛林琳,蔡莉,臧家兰.聚集素在非小细胞肺癌中的表达及意义[J].哈尔滨医科大学学报,2006,40(3):201-203. 被引量:4
  • 3Blaschuk O,Burdzy K,Fritz IB.Purification and characterizationof a cell-aggregating factor(clusterin),the major glycoproteinin ram rete testis fluid[J].J Biol Chem,1983,258(12):7714-7720.
  • 4Trougakso IP,So A,Jansen B,et al.Silencing expression ofthe clusterin/apolipoprotein J gene in human cancer cellsusing small interfering RNA induces spontaneous apoptosis,reduced growth ability,and cell sensitization to genotoxic andoxidative stress[J].Cancer Res,2004,64(5):1834-1842.
  • 5Won YS,Lee SJ,Yeo SG,et al.Effects of female sexhormones on clusterin expression and paclitaxel resistance inendometrial cancer cell lines[J].Int J Med Sci,2012,9(1):86-92.
  • 6Sabatte J,Faigle W,Ceballos A,et al.Semen clusterin is anovel DC-SIGN ligand[J].J Immunol,2011,187(10):5299-5309.
  • 7Zoubeidi A,Ettinger S,Beraldi E,et al.Clusterin facilitatesCOMMD1and I-kappaB degradation to enhance NF-kappaBactivity in prostate cancer cells[J].Mol Cancer Res,2010,8(1):119-130.
  • 8Xie D,Lau SH,Sham JS,et al.Up-regulated expression ofcytoplasmic clusterin in human ovarian carcinoma[J].Cancer,2005,103(2):277-283.
  • 9Moretti RM,Mai S,Montagnani Marelli M,et al.Molecularmechanisms of the antimetastatic activity of nuclear clusterinin prostate cancer cells[J].Int J Oncol,2011,39(1):225-234.
  • 10Chung J,Kwak C,Jin RJ,et al.Enhanced chemosensitivity ofbladder cancer cells to cisplatin by suppression of clusterin invitro[J].Cancer Lett,2004,203(2):155-161.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部